ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 281613 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 281613; 2) Community: the network communities that were significantly associated with the response to NSC 281613; 3) Molecule: the relationships between components within communities and NSC 281613; 4) MDR: the compounds that were significantly associated with the NSC 281613.

NSC Compound Enrichment Correlation
NSC 716766 Null 0.0223138217461955 0.26818393
NSC 717696 Oligomycin C 0.0223138217461955 0.0042799868
NSC 7223 Acid Chrome Black ethyl 0.0223138217461955 0.073149194
NSC 72942 DL-Noformicin 0.0223138217461955 -0.0030662447
NSC 734872 5,6-Dihydro-6-(3-dimethylamino-1-propyl)-3-nitro-5,11-dioxo- 11H-indeno[1,2-c]isoquinoline 0.0223138217461955 0.43604955
NSC 742295 (11aS)-8-(5-[4-(1,3-benzothiazol-2-yl)phenoxy]pentyloxy)-7-methoxy-2,3,5,11a-tetrahydro-1H-benzo[e]pyrrolo[1,2-a][1,4]diazepin-5-one 0.0223138217461955 0.21671771
NSC 750180 Null 0.0223138217461955 0.019586839
NSC 752330 6-(2-(propan-2-ylidene)hydrazinyl)-9H-purine-9-beta-D-riboside 0.0223138217461955 0.22031726
NSC 756319 GW694590A 0.0223138217461955 0.046931084
NSC 761560 N-(3-(1H-imidazol-1-yl)propyl)-4-(1-(3,5,5,8,8-pentamethyl-5,6,7,8 tetrahydronaphthalen-2-yl)vinyl)benzamide 0.0223138217461955 -0.1454923
Total:61  Current:28    [First] [Prev] [Next] [Last]